Keynote
Tuesday, September 26
08:45 AM - 09:15 AM
Live in Berlin
Less Details
Artificial intelligence (AI) has revolutionized industries across the board, and pharmaceutical manufacturing is no exception gradually embracing its potential. Although traditionally more conservative, the pharmaceutical industry has recognized the transformative potential of AI. While AI has already made a significant impact in drug discovery, it is also being utilized to improve manufacturing processes. Through AI algorithms, manufacturers can monitor and control these processes with greater precision, minimizing the risk of errors and ensuring adherence to required quality standards. Additionally, AI can proactively identify potential issues before they manifest, enabling corrective measures to be taken preemptively. With very sophisticated MES solutions that are tailored to the needs of the pharmaceutical industry already in place, how can AI provide additional value? Would AI be a solution to accelerate creation and review of complex MBRs and support the release of batches? Join us as we delve into the realm of Artificial Intelligence in Pharmaceutical Manufacturing, uncovering its present achievements and charting a course toward a future enriched with AI-enabled advancements.
This presentation covers:
With over 20 years of experience in the pharmaceutical industry, Hernan is a healthcare digital leader driving innovation and transformation across diverse domains. From site operations to global programs, he has successfully navigated increasingly challenging roles, leveraging his expertise in Manufacturing Operations Management (MES/MOM), Enterprise Manufacturing Intelligence (EMI), Shop Floor integration, Process Automation, and more.
His comprehensive knowledge extends to areas such as Supply Chain Serialization, Quality Assurance, Laboratory systems, Digital Tech Transfer, Cloud adoption in a GxP environment, and AI/ML implementation. This expertise enables him to achieve operational excellence and optimize processes while prioritizing the needs of users and patients.
By staying attuned to industry trends, disruptive technologies, benchmarks, and best practices, Hernan empowers his teams to generate fresh ideas and embrace innovative problem-solving approaches. He proactively assesses the potential impact of emerging trends on his company's strategic direction.
Throughout his career, Hernan has successfully led and delivered company-wide transformational programs, streamlining the IT/OT landscape and harmonizing processes. His dedication to driving digital business transformations is unwavering as he passionately harnesses digital technologies and innovative business models to elevate performance and create sustainable value.
Thomas Halfmann is a long-time industry veteran and an advocate of digitalization in Pharmaceutical Production and Supply Chain with more than 30 years of experience in manufacturing IT and automation. After various management positions at Novartis, including Head Global Project Office, Global MES Program Manager and Global Head Biopharmaceutical Operations IT, Thomas co-founded the international life sciences consulting group HGP in 2008. HGP was acquired by NNIT in 2019. From October 2019 Thomas was the Global Head Production & Laboratory for NNIT. Since March 2023 he is focusing on research of how digitalization can improve pharmaceutical manufacturing in a fully integrated IT and automation landscape. Thomas is a frequent speaker at international life sciences conferences, author of various publications and member of various industry associations and working groups.